Bristol Myers Squibb
(NYSE) BMY
Bristol Myers Squibb Financials at a Glance
Market Cap
$119.21B
Revenue (TTM)
$48.19B
Net Income (TTM)
$7.05B
EPS (TTM)
$3.46
P/E Ratio
16.93
Dividend
$2.49
Beta (Volatility)
0.30 (Low)
Dividend
$2.49
Beta (Volatility)
0.30 (Low)
Price
$59.74
Volume
398,020
Open
$59.34
Price
$59.74
Volume
398,020
Open
$59.34
Previous Close
$59.74
Daily Range
$59.08 - $60.06
52-Week Range
$42.52 - $62.89
Dividend
$2.49
Beta (Volatility)
0.30 (Low)
Price
$59.74
Volume
398,020
Open
$59.34
Previous Close
$59.74
Daily Range
$59.08 - $60.06
52-Week Range
$42.52 - $62.89
BMY News
BMY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bristol Myers Squibb
Industry
Pharmaceuticals
Sector
Health CareEmployees
32,500
CEO
Christopher S. Boerner, PhD, MBA
Website
www.bms.comHeadquarters
Princeton, NJ 08543, US
BMY Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
26%
Net Income Margin
15%
Return on Equity
41%
Return on Capital
19%
Return on Assets
8%
Earnings Yield
5.91%
Dividend Yield
0.04%
Payout Ratio
71.53%
Stock Overview
Market Cap
$119.21B
Shares Outstanding
2.04B
Volume
398.02K
Short Interest
0.00%
Avg. Volume
13.25M
Financials (TTM)
Gross Profit
$32.60B
Operating Income
$12.70B
EBITDA
$14.54B
Operating Cash Flow
$14.16B
Capital Expenditure
$1.31B
Free Cash Flow
$12.85B
Cash & ST Invst.
$10.67B
Total Debt
$47.14B
Bristol Myers Squibb Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.50B
+1.3%
Gross Profit
$8.40B
+13.2%
Gross Margin
67.23%
N/A
Market Cap
$119.21B
N/A
Market Cap/Employee
$3.50M
N/A
Employees
34,100
N/A
Net Income
$1.09B
+1408.3%
EBITDA
$2.19B
-14.0%
Quarterly Fundamentals
Net Cash
$36.47B
+9.6%
Accounts Receivable
$14.53B
+0.7%
Inventory
$2.69B
+5.2%
Long Term Debt
$44.68B
-8.8%
Short Term Debt
$2.46B
+10.6%
Return on Assets
7.83%
N/A
Return on Invested Capital
19.06%
N/A
Free Cash Flow
$1.60B
-60.5%
Operating Cash Flow
$1.97B
-55.5%